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Recent studies have shown sucralfate to have cytoprotective features in addition to its known antipepsin and antacid effects. This drug has been shown in limited studies to prevent gastric salicylate injury with pretreatment. A role for sucralfate in the nonulcer population, patients with gastritis, esophagitis, stomatitis, while promising, has not been clearly established and needs to be defined with further studies.